checkAd

     117  0 Kommentare Nordson Corporation Reports First Quarter Fiscal 2024 Results and Narrows Annual Guidance

    Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal first quarter ended January 31, 2024. Sales were $633 million, a 4% increase compared to the prior year’s first quarter sales of $610 million. The increase in first quarter 2024 sales included a favorable acquisition impact of 5%, partially offset by an organic sales decrease of 2%. The organic sales decrease was driven by ongoing pressure in electronics product lines, partially offset by growth in medical interventional, industrial and polymer processing product lines.

    Net income was $110 million, or $1.90 of earnings per diluted share, compared to prior year’s first quarter net income of $104 million, or $1.81 of earnings per diluted share. Adjusted net income was $128 million, a $4 million increase from the prior year adjusted net income of $123 million. First quarter 2024 adjusted earnings per diluted share were $2.21, a 3% increase from the prior year adjusted earnings per diluted share of $2.14. The increase was driven by higher operating profit, partially offset by increased interest expense.

    EBITDA in the first quarter was $197 million, or 31% of sales, compared to prior year EBITDA of $181 million, or 30% of sales. The 9% increase in EBITDA was a result of higher operating profit, driven by improved gross margins year-over-year.

    Commenting on the Company’s fiscal 2024 first quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “Sales results were in line with our first quarter expectations. The segments delivered a strong operating performance exceeding our first quarter earnings guidance. This is a great example of our entrepreneurial teams using NBS Next to meet the needs of our customers, while also taking strategic actions that position them for future profitable growth. I am particularly pleased with the solid performance of our IPS and MFS segments during the quarter, while ATS continued to manage the ongoing weakness of the electronics end market. The ARAG acquisition integration continued to make steady progress and contributed to our sales and EBITDA margin performance in the quarter.”

    First Quarter Segment Results

    Industrial Precision Solutions sales of $355 million increased 14% from the prior year, inclusive of an 11% acquisition impact. The organic sales increase of 2% was driven primarily by industrial coatings, polymer processing and nonwovens product lines. Operating profit was $108 million, an increase of $6 million from the prior year. EBITDA in the quarter was $126 million, or 36% of sales, a 16% increase from the prior year first quarter EBITDA of $109 million, or 35% of sales. The year-over-year increase was driven by the ARAG acquisition and higher organic sales and gross profit.

    Medical and Fluid Solutions sales of $160 million increased 3% compared to the prior year first quarter. The increase was driven by growth in the medical interventional solutions product lines. Operating profit was $46 million, an increase of $7 million from the prior year. EBITDA in the quarter was $60 million, or 37% of sales, a 13% increase from the prior year first quarter EBITDA of $53 million, or 34% of sales. The increase in EBITDA was driven by both higher sales and improved gross margins.

    Advanced Technology Solutions sales of $119 million decreased 18% compared to the prior year first quarter. The organic sales decrease was driven by weakness across the segment, primarily electronics dispense products serving semiconductor end markets. Operating profit was $19 million, an increase of $2 million from the prior year amount, which included acquisition-related expenses for the CyberOptics acquisition. EBITDA in the quarter was $22 million, or 19% of sales, a 28% decrease from the prior year first quarter EBITDA of $31 million, or 21% of sales. The decrease was driven by lower sales.

    Outlook

    The Company is entering the second quarter of fiscal 2024 with approximately $750 million in backlog, which continues to normalize and remain concentrated in systems businesses. Based on current visibility and order entry trends, the Company is narrowing its previously issued full-year revenue growth to 4% to 7% over record fiscal 2023 and adjusted earnings per diluted share to the range of $10.00 to $10.50 per diluted share. Second quarter fiscal 2024 sales are forecasted in the range of $645 to $670 million with adjusted earnings in the range of $2.20 to $2.35 per diluted share.

    As previously announced, the Company’s definition of adjusted earnings now excludes acquisition related amortization for both current and historical periods. It is not possible for the Company to identify the amount or significance of future adjustments associated with acquisition and integration costs, restructuring costs, acquisition-related amortization, certain non-operating or income tax items, or other non-routine costs that the Company adjusts in the presentation of adjusted earnings guidance. These items are dependent on future events that are not reasonably estimable at this time. Accordingly, the Company is unable to reconcile without unreasonable effort the forecasted range of adjusted earnings guidance to a comparable GAAP range.

    Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Thursday, February 22, 2024, at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. For persons unable to listen to the live broadcast, a replay will be available for 14 days after the event. Information about Nordson’s investor relations and shareholder services is available from Lara Mahoney, vice president, investor relations and corporate communications at (440) 204-9985 or lara.mahoney@nordson.com.

    Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions, including the Company’s ability to successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflict between Russia and Ukraine, acts of terror, natural disasters and pandemics, including the recent coronavirus (COVID-19) pandemic and the other factors discussed in Item 1A (Risk Factors) in the Company’s most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully. The Company undertakes no obligation to update or revise any forward-looking statement in this press release.

    Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com, linkedin/Nordson, or www.facebook.com/nordson.

     

    NORDSON CORPORATION

     

    CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

    (Dollars in thousands except for per-share amounts)

     

     

    Three Months Ended

     

    January 31,

    2024

     

    January 31,

    2023

    Sales

    $

    633,193

     

     

    $

    610,477

     

    Cost of sales

     

    284,766

     

     

     

    281,610

     

    Gross profit

     

    348,427

     

     

     

    328,867

     

    Gross margin %

     

    55.0

    %

     

     

    53.9

    %

     

     

     

     

    Selling & administrative expenses

     

    188,992

     

     

     

    184,648

     

    Operating profit

     

    159,435

     

     

     

    144,219

     

     

     

     

     

    Interest expense - net

     

    (20,398

    )

     

     

    (9,943

    )

    Other expense - net

     

    (338

    )

     

     

    (3,196

    )

    Income before income taxes

     

    138,699

     

     

     

    131,080

     

     

     

     

     

    Income taxes

     

    29,127

     

     

     

    26,819

     

     

     

     

     

    Net income

    $

    109,572

     

     

    $

    104,261

     

     

     

     

     

    Weighted-average common shares outstanding:

     

     

     

    Basic

     

    57,064

     

     

     

    57,170

     

    Diluted

     

    57,555

     

     

     

    57,762

     

     

     

     

     

    Earnings per share:

     

     

     

    Basic earnings

    $

    1.92

     

     

    $

    1.82

     

    Diluted earnings

    $

    1.90

     

     

    $

    1.81

     

     

    NORDSON CORPORATION

     

    CONSOLIDATED BALANCE SHEETS (Unaudited)

    (Dollars in thousands)

     

     

    January 31, 2024

     

    October 31, 2023

    Cash and cash equivalents

    $

    136,201

     

    $

    115,679

    Receivables - net

     

    537,702

     

     

     

    590,886

     

    Inventories - net

     

    451,217

     

     

     

    454,775

     

    Other current assets

     

    82,992

     

     

     

    67,970

     

    Total current assets

     

    1,208,112

     

     

     

    1,229,310

     

     

     

     

     

    Property, plant and equipment - net

     

    394,467

     

     

     

    392,846

     

    Goodwill

     

    2,805,086

     

     

     

    2,784,201

     

    Other assets

     

    839,412

     

     

     

    845,413

     

     

    $

    5,247,077

     

     

    $

    5,251,770

     

     

     

     

     

    Notes payable and debt due within one year

    $

    116,585

     

     

    $

    115,662

     

    Accounts payable and accrued liabilities

     

    435,095

     

     

     

    466,427

     

    Total current liabilities

     

    551,680

     

     

     

    582,089

     

     

     

     

     

    Long-term debt

     

    1,513,871

     

     

     

    1,621,394

     

    Other liabilities

     

    457,559

     

     

     

    450,227

     

    Total shareholders' equity

     

    2,723,967

     

     

     

    2,598,060

     

     

    $

    5,247,077

     

     

    $

    5,251,770

     

     

     

     

     

     

    NORDSON CORPORATION

     

    CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

     

    January 31,

    2024

     

    January 31,

    2023

    Cash flows from operating activities:

     

     

     

    Net income

    $

    109,572

     

     

    $

    104,261

     

    Depreciation and amortization

     

    33,544

     

     

     

    26,434

     

    Other non-cash items

     

    6,552

     

     

     

    6,224

     

    Changes in working capital

     

    14,614

     

     

     

    (58,371

    )

    Other

     

    8,074

     

     

     

    44,789

     

    Net cash provided by operating activities

     

    172,356

     

     

     

    123,337

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

    Additions to property, plant and equipment

     

    (7,530

    )

     

     

    (9,302

    )

    Acquisition of businesses, net of cash acquired

     

     

     

     

    (377,843

    )

    Other - net

     

    1,805

     

     

     

    9

     

    Net cash used in investing activities

     

    (5,725

    )

     

     

    (387,136

    )

     

     

     

     

    Cash flows from financing activities:

     

     

     

    Issuance (repayment) of long-term debt

     

    (107,195

    )

     

     

    252,278

     

    Repayment of finance lease obligations

     

    (1,488

    )

     

     

    (1,318

    )

    Dividends paid

     

    (38,855

    )

     

     

    (37,199

    )

    Issuance of common shares

     

    14,418

     

     

     

    8,807

     

    Purchase of treasury shares

     

    (7,371

    )

     

     

    (6,875

    )

    Net cash provided (used) in financing activities

     

    (140,491

    )

     

     

    215,693

     

     

     

     

     

    Effect of exchange rate change on cash:

     

    (5,618

    )

     

     

    6,643

     

    Net change in cash and cash equivalents

     

    20,522

     

     

     

    (41,463

    )

     

     

     

     

    Cash and cash equivalents:

     

     

     

    Beginning of period

     

    115,679

     

     

     

    163,457

     

    End of period

    $

    136,201

     

     

    $

    121,994

     

     

     

     

     

     

    NORDSON CORPORATION

     

    SALES BY GEOGRAPHIC SEGMENT (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

     

    Sales Variance

     

    January 31,

    2024

     

    January 31,

    2023

     

    Organic

     

    Acquisitions

     

    Currency

     

    Total

    SALES BY SEGMENT

     

     

     

     

     

     

     

     

     

     

     

    Industrial Precision Solutions

    $

    354,547

     

    $

    311,546

     

    2.3

    %

     

    10.6

    %

     

    0.9

    %

     

    13.8

    %

    Medical and Fluid Solutions

     

    159,526

     

     

     

    154,287

     

     

    3.1

    %

     

    %

     

    0.3

    %

     

    3.4

    %

    Advanced Technology Solutions

     

    119,120

     

     

     

    144,644

     

     

    (17.6

    )%

     

    %

     

    %

     

    (17.6

    )%

    Total sales

    $

    633,193

     

     

    $

    610,477

     

     

    (2.2

    )%

     

    5.4

    %

     

    0.5

    %

     

    3.7

    %

     

     

     

     

     

     

     

     

     

     

     

     

    SALES BY GEOGRAPHIC REGION

     

     

     

     

     

     

     

     

     

     

     

    Americas

    $

    274,012

     

     

    $

    264,878

     

     

    (0.3

    )%

     

    3.1

    %

     

    0.6

    %

     

    3.4

    %

    Europe

     

    179,310

     

     

     

    162,939

     

     

    (7.0

    )%

     

    14.2

    %

     

    2.8

    %

     

    10.0

    %

    Asia Pacific

     

    179,871

     

     

     

    182,660

     

     

    (0.5

    )%

     

    0.7

    %

     

    (1.7

    )%

     

    (1.5

    )%

    Total sales

    $

    633,193

     

     

    $

    610,477

     

     

    (2.2

    )%

     

    5.4

    %

     

    0.5

    %

     

    3.7

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    NORDSON CORPORATION

     

    RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

     

    January 31,

    2024

     

    January 31,

    2023

    Net income

    $

    109,572

     

    $

    104,261

    Income taxes

     

    29,127

     

     

     

    26,819

     

    Interest expense - net

     

    20,398

     

     

     

    9,943

     

    Other expense - net

     

    338

     

     

     

    3,196

     

    Depreciation and amortization

     

    33,544

     

     

     

    26,434

     

    Inventory step-up amortization (1)

     

    2,944

     

     

     

    4,306

     

    Acquisition-related costs (1)

     

    597

     

     

     

    5,989

     

    EBITDA (non-GAAP) (2)

    $

    196,520

     

     

    $

    180,948

     

    (1)

    Represents fees, severance and non-cash inventory charges associated with acquisitions.

    (2)

    EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.

     

    NORDSON CORPORATION

     

    RECONCILIATION OF NON-GAAP MEASURES - EBITDA (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

     

    January 31, 2024

     

    January 31, 2023

    SALES BY SEGMENT

     

     

     

     

     

     

     

    Industrial Precision Solutions

    $

    354,547

     

     

     

     

    $

    311,546

     

     

     

    Medical and Fluid Solutions

     

    159,526

     

     

     

     

     

    154,287

     

     

     

    Advanced Technology Solutions

     

    119,120

     

     

     

     

     

    144,644

     

     

     

    Total sales

    $

    633,193

     

     

     

     

    $

    610,477

     

     

     

     

     

     

     

     

     

     

     

    OPERATING PROFIT

     

     

     

     

     

     

     

    Industrial Precision Solutions

    $

    108,364

     

     

     

     

    $

    102,319

     

     

     

    Medical and Fluid Solutions

     

    46,100

     

     

     

     

     

    39,384

     

     

     

    Advanced Technology Solutions

     

    19,038

     

     

     

     

     

    16,963

     

     

     

    Corporate

     

    (14,067

    )

     

     

     

     

    (14,447

    )

     

     

    Total operating profit

    $

    159,435

     

     

     

     

    $

    144,219

     

     

     

     

     

     

     

     

     

     

     

    OPERATING PROFIT ADJUSTMENTS (1)

     

     

     

     

    Industrial Precision Solutions

    $

    3,541

     

     

     

     

    $

     

     

     

    Advanced Technology Solutions

     

     

     

     

     

     

    10,295

     

     

     

    Total adjustments

    $

    3,541

     

     

     

     

    $

    10,295

     

     

     

     

     

     

     

     

     

     

     

    DEPRECIATION & AMORTIZATION

     

     

     

     

     

     

    Industrial Precision Solutions

    $

    14,380

     

     

     

     

    $

    6,845

     

     

     

    Medical and Fluid Solutions

     

    13,705

     

     

     

     

     

    13,625

     

     

     

    Advanced Technology Solutions

     

    3,441

     

     

     

     

     

    3,812

     

     

     

    Corporate

     

    2,018

     

     

     

     

     

    2,152

     

     

     

    Total depreciation & amortization

    $

    33,544

     

     

     

     

    $

    26,434

     

     

     

     

     

     

     

     

     

     

     

    EBITDA (NON-GAAP) (2)

     

     

     

     

     

     

     

    Industrial Precision Solutions

    $

    126,285

     

     

    36%

     

    $

    109,164

     

     

    35%

    Medical and Fluid Solutions

     

    59,805

     

     

    37%

     

     

    53,009

     

     

    34%

    Advanced Technology Solutions

     

    22,479

     

     

    19%

     

     

    31,070

     

     

    21%

    Corporate

     

    (12,049

    )

     

     

     

     

    (12,295

    )

     

     

    Total EBITDA

    $

    196,520

     

     

    31%

     

    $

    180,948

     

     

    30%

     

     

     

     

     

     

     

     

    (1)

    Represents fees, severance and non-cash inventory charges associated with acquisitions.

    (2)

    EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.

     

    NORDSON CORPORATION

     

    RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

     

    January 31,

    2024

     

    January 31,

    2023

    GAAP AS REPORTED

     

     

     

    Operating profit

    $

    159,435

     

     

    $

    144,219

     

    Other / interest expense - net

     

    (20,736

    )

     

     

    (13,139

    )

    Net income

     

    109,572

     

     

     

    104,261

     

    Diluted earnings per share

    $

    1.90

     

     

    $

    1.81

     

     

     

     

     

    Shares outstanding - diluted

     

    57,555

     

     

     

    57,762

     

     

     

     

     

    OPERATING PROFIT ADJUSTMENTS

     

     

     

    Inventory step-up amortization

    $

    2,944

     

     

    $

    4,306

     

    Acquisition-related costs

     

    597

     

     

     

    5,989

     

     

     

     

     

    ACQUISITION AMORTIZATION OF INTANGIBLES

    $

    19,387

     

     

    $

    13,872

     

     

     

     

     

    Total adjustments

    $

    22,928

     

     

    $

    24,167

     

     

     

     

     

    Adjustments net of tax

    $

    18,113

     

     

    $

    19,223

     

    EPS effect of adjustments and other discrete tax items

    $

    0.31

     

     

    $

    0.33

     

     

     

     

     

    NON-GAAP MEASURES-ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

     

     

     

    Adjusted Net income (1)

    $

    127,685

     

     

    $

    123,484

     

    Adjusted Diluted earnings per share (2)

    $

    2.21

     

     

    $

    2.14

     

    (1)

    Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items.

    (2)

    Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items.

     

     

     

    Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS and EBITDA, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.

     


    The Nordson Stock at the time of publication of the news with a fall of -1,23 % to 241EUR on Lang & Schwarz stock exchange (21. Februar 2024, 22:30 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Nordson Corporation Reports First Quarter Fiscal 2024 Results and Narrows Annual Guidance Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal first quarter ended January 31, 2024. Sales were $633 million, a 4% increase compared to the prior year’s first quarter sales of $610 million. The increase in first quarter …

    Schreibe Deinen Kommentar

    Disclaimer